FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:1672-1674 May 27, 1999 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Zhang, L. Related Article by Furtado, M. R. PubMed Citation

Over the past 18 years the human immunodeficiency virus type 1 (HIV-1) epidemic has evolved, with the disease shifting from a syndrome whose cause was undefined to one in which the etiologic agent of AIDS was isolated and identified, but for which therapeutic options were limited. We are now in a new era characterized by efficient therapeutic agents to combat HIV-1 in many patients. This progress has been based on the development of highly active antiretroviral therapy in which combinations of agents are given that inhibit HIV-1 replication in vivo. Although vaccines are still under development and critical issues such . . . [Full Text of this Article]

References

Related Letters:

Control of HIV despite the Discontinuation of Antiretroviral Therapy
Lisziewicz J., Rosenberg E., Lieberman J., Jessen H., Lopalco L., Siliciano R., Walker B., Lori F.
Extract | Full Text  
N Engl J Med 1999; 340:1683, May 27, 1999. Correspondence

This article has been cited by other articles:

• Hughes, T., Deininger, M., Hochhaus, A., Branford, S., Radich, J., Kaeda, J., Baccarani, M., Cortes, J., Cross, N. C. P., Druker, B. J., Gabert, J., Grimwade, D., Hehlmann, R., Kamel-Reid, S., Lipton, J. H., Longtine, J., Martinelli, G., Saglio, G., Soverini, S., Stock, W., Goldman, J. M. (2006). Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood 108: 28-37 [Abstract] [Full Text]  
• Di Mascio, M., Dornadula, G., Zhang, H., Sullivan, J., Xu, Y., Kulkosky, J., Pomerantz, R. J., Perelson, A. S. (2003). In a Subset of Subjects on Highly Active Antiretroviral Therapy, Human Immunodeficiency Virus Type 1 RNA in Plasma Decays from 50 to <5 Copies per Milliliter, with a Half-Life of 6 Months. J. Virol. 77: 2271-2275 [Abstract] [Full Text]  
• Solas, C., Lafeuillade, A., Halfon, P., Chadapaud, S., Hittinger, G., Lacarelle, B. (2003). Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients. Antimicrob. Agents Chemother. 47: 238-243 [Abstract] [Full Text]  
• Kostrikis, L. G., Touloumi, G., Karanicolas, R., Pantazis, N., Anastassopoulou, C., Karafoulidou, A., Goedert, J. J., Hatzakis, A. (2002). Quantitation of Human Immunodeficiency Virus Type 1 DNA Forms with the Second Template Switch in Peripheral Blood Cells Predicts Disease Progression Independently of Plasma RNA Load. J. Virol. 76: 10099-10108 [Abstract] [Full Text]  
• Crowe, S. M., Sonza, S. (2000). HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication. J. Leukoc. Biol. 68: 345-350 [Abstract] [Full Text]  
• Henry, K. (2000). The Case for More Cautious, Patient-Focused Antiretroviral Therapy. ANN INTERN MED 132: 306-311 [Abstract] [Full Text]  
• Dornadula, G., Zhang, H., VanUitert, B., Stern, J., Livornese, L. Jr, Ingerman, M. J., Witek, J., Kedanis, R. J., Natkin, J., DeSimone, J., Pomerantz, R. J. (1999). Residual HIV-1 RNA in Blood Plasma of Patients Taking Suppressive Highly Active Antiretroviral Therapy. JAMA 282: 1627-1632 [Abstract] [Full Text]  
• Fauci, A. S. (1999). The AIDS Epidemic -- Considerations for the 21st Century. NEJM 341: 1046-1050 [Full Text]  
• (1999). Eradicating HIV: No Time Soon. AIDS Clin Care 1999: 3-3 [Full Text]